scholarly article | Q13442814 |
P50 | author | Qing Chang | Q87613419 |
P2093 | author name string | Ming Zhang | |
Yan Liu | |||
Jing Zhang | |||
Min Ding | |||
Na Li | |||
Tao Jiang | |||
Chen Zheng | |||
Xiao-Yu Wu | |||
Yong-Xiao Li | |||
Yu-Feng Wu | |||
Zhen-Wei Yu | |||
Li-Wei Shao | |||
Dan-Feng Zheng | |||
Xue-Ling Qi | |||
P2860 | cites work | Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions | Q22009563 |
Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease | Q24291767 | ||
Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
Subgroup-specific structural variation across 1,000 medulloblastoma genomes | Q28271811 | ||
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles | Q28481626 | ||
A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells | Q28551285 | ||
Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression | Q28598223 | ||
Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor | Q33211941 | ||
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma | Q33740695 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas | Q34202479 | ||
Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor | Q34316845 | ||
Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer | Q35158541 | ||
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas | Q35194198 | ||
Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling | Q35587662 | ||
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples | Q35837393 | ||
Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders. | Q35877637 | ||
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 | ||
Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence | Q36712351 | ||
Genetic grouping of medulloblastomas by representative markers in pathologic diagnosis | Q36865020 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
Signaling pathway and molecular subgroups of medulloblastoma | Q36956174 | ||
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review). | Q36983860 | ||
Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma. | Q37256791 | ||
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis | Q37636027 | ||
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. | Q38374250 | ||
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients | Q38879941 | ||
Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma. | Q38940977 | ||
Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor | Q39334547 | ||
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma | Q40193200 | ||
Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors | Q40347013 | ||
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease | Q40781851 | ||
ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients | Q41333109 | ||
Festination Correlates with SNCA Polymorphism in Chinese Patients with Parkinson's Disease. | Q42188620 | ||
Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models | Q43096504 | ||
The whole-genome landscape of medulloblastoma subtypes | Q46567834 | ||
Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma. | Q48162943 | ||
Histones facilitate α-synuclein aggregation during neuronal apoptosis | Q48386650 | ||
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. | Q55469539 | ||
alpha-Synuclein is expressed in a variety of brain tumors showing neuronal differentiation. | Q55476143 | ||
P433 | issue | 4 | |
P921 | main subject | biomarker | Q864574 |
tumor invasion | Q60750433 | ||
P304 | page(s) | 1263-1275 | |
P577 | publication date | 2018-02-20 | |
P1433 | published in | Cancer Science | Q326125 |
P1476 | title | SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis | |
P478 | volume | 109 |